Article info

Download PDFPDF
Original research
Safety and efficacy of ticagrelor as single antiplatelet therapy in prevention of thromboembolic complications associated with the Pipeline Embolization Device (PED): multicenter experience

Authors

  1. Correspondence to Professor Ahmed Elbassiouny, Department of Neurology, Ain Shams University Faculty of Medicine, Cairo 11566, Egypt; ahmedelbassiony{at}gmail.com
View Full Text

Citation

Mohammaden MH, English SW, Stapleton CJ, et al
Safety and efficacy of ticagrelor as single antiplatelet therapy in prevention of thromboembolic complications associated with the Pipeline Embolization Device (PED): multicenter experience

Publication history

  • Received March 1, 2020
  • Revised April 8, 2020
  • Accepted April 10, 2020
  • First published May 29, 2020.
Online issue publication 
October 15, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.